ASTH - Astrana Health, Inc.
NEXT EARNINGS:
Mar 2, 2026
(in 5 days)
EPS Est: $0.15
|
Rev Est: $930.5M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$32.75
DETAILS
HIGH:
$40.00
LOW:
$26.00
MEDIAN:
$32.50
CONSENSUS:
$32.75
UPSIDE:
70.40%
Market Cap:
963.99M
Volume:
317,083
Avg Volume:
530,821
52 Week Range:
18.08-36.2
Sector:
Healthcare
Industry:
Medical - Care Facilities
Beta:
0.89
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
1,900
IPO Date:
2009-03-11
EPS (TTM):
0.91
P/E Ratio:
34.85
Revenue (TTM):
2.03B
Total Assets:
1.35B
Total Debt:
471.84M
Cash & Equiv:
288.45M
Rev Growth (5Y):
29.4%
EPS Growth (5Y):
17.3%
FCF Growth (5Y):
28.4%
ROCE:
11.5%
Debt/Equity:
0.66
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $0.01 | $0.47 | -97.9% | $956.0M | $930.5M | +2.7% |
| 2025-08-07 | $0.19 | $0.36 | -47.2% | $654.8M | $943.7M | -30.6% |
| 2025-05-08 | $0.14 | $0.23 | -39.1% | $620.4M | $630.7M | -1.6% |
| 2025-02-27 | $-0.15 | $0.22 | -168.2% | $665.2M | $617.2M | +7.8% |
| 2024-11-07 | $0.33 | $0.32 | +3.1% | $478.7M | $613.0M | -21.9% |
| 2024-08-07 | $0.40 | $0.39 | +2.6% | $486.3M | $440.8M | +10.3% |
| 2024-05-07 | $0.31 | $0.30 | +3.3% | $404.4M | $413.9M | -2.3% |
| 2024-02-27 | $0.26 | $0.15 | +73.3% | $353.0M | $341.2M | +3.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.03B | 1.39B | 1.14B | 773.91M | 370.25M | 560.62M | 519.91M | 357.75M | 44.05M |
| Net Income | 43.15M | 60.72M | 45.17M | 68.92M | (23.75M) | 14.12M | 10.84M | 25.80M | (9.34M) |
| EPS | 0.91 | 1.30 | 1.00 | 1.57 | 1.04 | 0.41 | 0.33 | 1.01 | 0.00 |
| Total Assets | 1.35B | 933.36M | 966.21M | 867.36M | 817.49M | 728.71M | 513.00M | 490.64M | 19.57M |
| Total Debt | 471.84M | 321.01M | 229.36M | 200.98M | 260.56M | 256.55M | 13.66M | 6.25M | 188,764 |
| Cash & Equivalents | 288.45M | 293.81M | 288.03M | 233.10M | 193.47M | 103.19M | 106.89M | 119.77M | 9.27M |
| Operating Cash Flow | 52.20M | 68.23M | 82.13M | 70.33M | 46.16M | 13.67M | 26.10M | 53.07M | (1.84M) |
| Free Cash Flow | 44.17M | 39.70M | 59.19M | 51.11M | 45.00M | 12.63M | 24.93M | 50.99M | (2.10M) |
| FCF per Share | 0.93 | 0.85 | 1.32 | 1.17 | 1.23 | 0.36 | 0.76 | 2.00 | N/A |
| Book Value | 712.72M | 614.22M | 542.56M | 448.17M | 330.82M | 191.55M | 180.55M | 159.95M | 5.81M |
| Cash & ST Investments | 290.83M | 296.31M | 293.59M | 286.51M | 261.17M | 219.73M | 108.02M | 120.92M | 9.27M |
| ROC Equity | 0.06 | 0.10 | 0.08 | 0.15 | -0.07 | 0.07 | 0.06 | 0.16 | -1.61 |